Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen

Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen

Giorgio L Colombo,1,2 Sergio Di Matteo,2 Franco Maggiolo31University of Pavia, Department of Drug Sciences, School of Pharmacy, Pavia, Italy, 2Studi Analisi Valutazioni Economiche, Milan, Italy, 3Division of Infectious Diseases, Ospedali Riuniti, Bergamo, ItalyBackground: The aim of this study was t...

Full description

Bibliographic Details
Main Authors:	Colombo GL, Di Matteo S, Maggiolo F
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-02-01
Series:	ClinicoEconomics and Outcomes Research
Online Access:	http://www.dovepress.com/antiretroviral-therapy-in-hiv-infected-patients-a-proposal-to-assess-t-a12187

Similar Items

Effectiveness of antiretroviral therapy in the single-tablet regimen era
by: Juliana de Oliveira Costa, et al.
Published: (2018-11-01)

Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
by: Maggiolo F, et al.
Published: (2015-02-01)

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines
by: Colombo GL, et al.
Published: (2013-10-01)

HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan
by: Tsai HC, et al.
Published: (2018-08-01)

Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
by: Hartmut Krentz PhD, et al.
Published: (2019-01-01)

HIV virologic response better with single-tablet once daily regimens compared to multiple-tablet daily regimens
by: Shashi N Kapadia, et al.
Published: (2018-12-01)

Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020
by: Rohan Khazanchi, et al.
Published: (2023-04-01)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa
by: Paton, N, et al.
Published: (2014)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
by: Paton, N, et al.
Published: (2014)

Antiretroviral regimens for preventing HIV infection in infants
by: René E. Ekpini, et al.
Published: (2005-07-01)

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.
by: Laurent Cotte, et al.
Published: (2017-01-01)

Characteristics of HIV antiretroviral regimen and treatment adherence
by: Vera Lúcia da Silveira, et al.

Towards an ideal antiretroviral regimen for the global HIV epidemic
by: Beatriz Grinsztejn, et al.
Published: (2017-07-01)

Trend of HIV Transmitted Drug Resistance After the Introduction of Single-Tablet Regimens in Southern Taiwan
by: Tsai HC, et al.
Published: (2022-09-01)

Effect of single tablet regimen on prescription trends for treatment-naïve patients with HIV/AIDS in Korea
by: Kyung Sun Oh, et al.
Published: (2022-02-01)

Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults
by: Anchalee Avihingsanon, et al.
Published: (2017-08-01)

Statistical process control of manufacturing tablets for antiretroviral therapy
by: Nataly Paredes da Rocha, et al.
Published: (2023-05-01)

Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.
by: Donna E Sweet, et al.
Published: (2016-01-01)

Evaluation of the Efficacy and Safety of Changes in Antiretroviral Regimens for HIV-infected Patients
by: Hiroyuki Tanaka, et al.
Published: (2014-07-01)

Incidence and Predictors of Initial Antiretroviral Therapy Regimen Change Among HIV-Infected Adults Receiving Antiretroviral Therapy at Arba Minch General Hospital, Southern Ethiopia
by: Gebremichael MA, et al.
Published: (2020-08-01)

Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
by: Sanjeev Sinha, et al.
Published: (2017-12-01)

Effectiveness of four antiretroviral regimens for treating people living with HIV.
by: Aracele Tenório de Almeida E Cavalcanti, et al.
Published: (2020-01-01)

Persistent intracellular HIV transcription in individuals on stable antiretroviral regimens
by: Dimitrios Pilalas, et al.
Published: (2018-05-01)

Circulating levels of inflammatory mediators in pregnant people living with HIV according to antiretroviral therapy regimen
by: Stephanie Hindle, et al.
Published: (2024-01-01)

Durability of single tablet regimen for patients with HIV infection in Southern Taiwan: data from a real-world setting
by: Hui-Min Chang, et al.
Published: (2022-01-01)

High Prevalence of Doravirine Resistance in HIV-1-Infected Patients with Virological Failure to an NNRTI-Based Single-Tablet Regimen
by: Tsai HC, et al.
Published: (2022-07-01)

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults
by: Edwin DeJesus, et al.
Published: (2019-05-01)

THE RESULTS OF THE EFFICACY AND SAFETY OF THE NEW RUSSIAN DRUG 6НР IN THE ANTIRETROVIRAL THERAPY REGIMENS OF HIV-INFECTED PATIENTS
by: A. V. Kravchenko, et al.
Published: (2019-03-01)

Modern antiretroviral regimens
by: A. V. Kravchenko
Published: (2016-12-01)

Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis.
by: Mario Cruciani, et al.
Published: (2019-01-01)

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens
by: Julie Priest, et al.
Published: (2023-08-01)

Antiretroviral therapy of acute HIV-infection
by: A V Kravchenko, et al.
Published: (2004-04-01)

Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)

Young HIV-infected children and their adult caregivers prefer tablets to syrup antiretroviral medications in Africa.
by: Patricia Nahirya-Ntege, et al.
Published: (2012-01-01)

When should children with HIV infection be started on antiretroviral therapy?
by: Steven B Welch, et al.
Published: (2008-03-01)

Negative effect of antiretroviral therapy on spermogram values in HIV-positive men
by: E. V. Mityurina, et al.
Published: (2019-04-01)

Suppression of HIV in the first 12 months of antiretroviral therapy: a comparative analysis of dolutegravir- and efavirenz-based regimens
by: Gabriella Jomara da Silva, et al.
Published: (2023-05-01)

Virological and immunological efficacy of metabolically favorable antiretroviral therapy regimens in HIV patients who had no previous treatment
by: E. I. Veselova, et al.
Published: (2020-06-01)

Economic Burden of HIV Antiretroviral Therapy Adverse Events in the United States
by: Mitch Dekoven MHSA, et al.
Published: (2016-01-01)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV.
by: Analú Correa, et al.
Published: (2020-01-01)